Coexpression of BMI-1 and EZH2 polycomb-group proteins is associated with cycling cells and degree of malignancy in B-cell non-Hodgkin lymphoma

Blood

Volumn 97, Issue 12, 2001, Pages 3896-3901

  Van Kemenade, Folkert J ^a,b   Raaphorst, Frank M ^a,b   Blokzijl, Tjasso ^a,b   Fieret, Elly ^a,b   Hamer, Karien M ^a,b   Satijn, David P E ^a,b   Otte, Arie P ^a,b   Meijer, Chris J L M ^a,b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

POLYCOMB GROUP PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; B LYMPHOCYTE; BURKITT LYMPHOMA; CANCER GRADING; CARCINOGENESIS; CARCINOGENICITY; CELL CYCLE; FOLLICULAR LYMPHOMA; GENE EXPRESSION; HEMATOPOIESIS; HUMAN; LYMPHOCYTOMA; MAJOR CLINICAL STUDY; MANTLE CELL LYMPHOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; TUMOR CELL;

EID: 0035877978     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.12.3896     Document Type: Article

References (32)

1. Küppers R, Klein U, Hansmann M-L, Rajewsky K. Cellular origin of human B-cell lymphomas. N Engl J Med. 1999;341:1520-1529.
2. Horning SJ, Rosenberg SA. The natural history of initially untreated low-grade non-Hodgkin lymphomas. N Engl J Med. 1984;311:1471-1475.
3. Federico M, Vitolo U, Zinzani PL, et al. Prognosis of follicular lymphoma: a predictive model based on a retrospective analysis of 987 cases. Blood. 2000;95:783-789.
4. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000;403:503-511.
5. Vanasse GJ, Concannon P, Willerford DM. Regulated genomic instability and neoplasia in the lymphoid lineage. Blood. 1999;94:3997-4010.
6. Warnke RA, Weiss LM, Chan JKC, Cleary ML, Dorfman RF. Malignant lymphomas: an overview. In: Rosai J, Sobin LH, eds. Tumors of the Lymph Nodes and Spleen. Bethesda, MD:AFIP; 1995:53-58.
7. Lamond AI, Earnshaw WC. Structure and function in the nucleus. Science. 1998;280:547-553.
8. Pirrotta V. Polycomb Silencing and the maintenance of stable chromatin states. In: Ohlsson R, ed. Results and Problems in Cell Differentiation: Genomic Imprinting. Berlin, Germany: Springer-Verlag; 1999:205-228.
9. Satijn DPE, Otte AP. Polycomb group protein complexes: do different complexes regulate distinct target genes? Biochim Biophys Acta. 1999;1447:1-16.
10. Jacobs JJL, Scheijen B, Voncken JW, Kieboom K, Berns AJM, van Lohuizen M. Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF. Genes Dev. 1999;13:2678-2690.
11. Satijn DPE, Olson DJ, van der Vlag J, et al. Interference with the expression of a novel human polycomb protein, hPc2, results in cellular transformation and apoptosis. Mol Cell Biol. 1997;17:6076-6086.
12. Satijn DPE, Otte AP. RING1 interacts with multiple polycomb-group proteins and displays tumorigenic activity. Mol Cell Biol. 1999;19:57-68.
13. Sewalt RGAB, van der Vlag J, Gunster MJ. et al. Characterization of interactions between the mammalian polycomb-group proteins Enx1/EZH2 and EED suggests the existence of different mammalian polycomb-group protein complexes. Mol Cell Biol. 1998;18:3586-3595.
14. van der Vlag J, Otte AP. Transcriptional repression mediated by the human polycomb protein EED involves histone deacylation. Nat Genet. 1999;23:474-478.
15. Bardos JI, Saurin AJ, Tissot C, Duprez E, Freemont PS. HPC3 is a new human polycomb orthologue that interacts and associates with RING1 and Bmi1 and has transcriptional repression properties. J Biol Chem. 2000;275:28785-28792.
16. Gunster MJ, Satijn DPE, Hamer KM, et al. Identification and characterization of interactions between the vertebrate polycomb-group protein BMI1 and human homologues of polyhomeotic. Mol Cell Biol. 1997;17:2326-2335.
17. Lessard J, Baban S, Sauvageau G. Stage-specific expression of polycomb group genes in human bone marrow. Blood. 1998;91:1216-1224.
18. van Lohuizen M. The trithorax groups and polycomb group chromatin modifiers: implications for disease. Curr Opin Genet Dev. 1999;9:355-361.
19. Lessard J, Schumacher A, Thorsteinsdottir U, van Lohuizen M, Magnuson T, Sauvageau G. Functional antagonism of the polycomb-group genes eed and Bmi-1 in hemopoietic cell proliferation. Genes Dev. 1999;13:2691-2703.
20. Raaphorst FM, van Kemenade FJ, Fieret JH, Satijn DPE, Otto AP, Meijer CJLM. Polycomb gene expression patterns reflect distinct B-cell differentiation stages in human germinal centers. J Immunol. 2000;164:1-4.
21. Raaphorst FM, van Kemenade FJ, Blokzij T, et al. Coexpression of BMI-1 and EZH2 polycomb group genes in Reed Sternberg cells of Hodgkin's disease. Am J Pathol. 2000;157:709-716.
22. Chan JKC, Banks PM, Cleary ML, et al. A revised European-American classification of lymphoid neoplasms proposed by the International Lymphoma Study Group. Am J Clin Pathol. 1995;103:543-560.
23. Harris NL, Jaffe ES, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphold tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol. 1999;17:3835-3849.
24. Mann RB, Berard CW. Criteria for the cytologic subclassification of follicular lymphomas: a proposed alternative method. Hematol Oncol. 1983;1:187-192.
25. Alkema MJ, Jacobs H, van Lohuizen M, Berns A. Perturbation of B and T cell development and predisposition to lymphomagenesis in Emu Bmi1 transgenic mice require the Bmi1 RING finger. Oncogene. 1997;15:899-910.
26. Haupt Y, Bath ML, Harris AW, Adams JM. Bmi-1 transgene induces lymphoma and collaborates with myc in tumorigenesis. Oncogene. 1993;8:3161-3164.
27. Fukuyama T, Otsuka T, Shigematsu H, et al. Proliferative involvement of ENX-1, a putative human polycomb group gene, in haematopoietic cells. Br J Haematol. 2000;108:842-847.
28. Voncken JW, Schweizer D, Aagaard L, Sattler L, Jantsch MF, van Lohuizen M. Chromatin-association of the Polycomb group protein BMI1 is cell cycle-regulated and correlates with its phosphorylation status. J Cell Sci. 1999;112:4627-4639.
29. Bea BS, Ribas M, Hernandez JM, et al. Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants. Blood. 1999;93:4365-4374.
30. Visser HPJ, Gunster MJ, Kluin-Nelemans HC, et al. The polycomb group protein EZH2 is up-regulated in proliferating, cultured human mantle cell lymphoma. Br J Haematol. 2001;112:950-958.
31. Raaphorst FM, Otte AP, van Kemenade FJ, Blokzijl T, Fieret JH, Hamer KM, Satijn DPE, Meijer CJLM. Distinct BMI-1 and EZH2 expression patterns in thymocytes and mature T cells suggest a role for polycomb genes in human T cell differentiation. J Immunol. In press.
32. Hashimoto N, Brock HW, Nomura M, Kyba M, Hodgson J, Fujita Y. RAE28, BMI1, and M33 are members of heterogeneous multimeric mammalian Polycomb group complexes. Biochem Biophys Res Commun. 1998;245:356-365.